Latest Shareholder Approval News

CAR Group announces a leadership transition with CFO William Elliott set to succeed long-serving CEO Cameron McIntyre, alongside an upbeat FY25 financial outlook signaling robust revenue and profit growth.

Pacific Edge Limited (ASX – PEB) has announced a securities purchase plan (SPP) aiming to raise up to NZD 5 million, contingent on shareholder approval of a prior NZD 16 million placement. The move is designed to bolster working capital amid ongoing growth initiatives.

Gold Road Resources has agreed to a $3.40 per share acquisition by Gold Fields, combining fixed and variable cash components tied to Northern Star shares. Meanwhile, Gruyere mine production remains steady, with costs edging higher and strong cash flow underpinning the company’s financial position.

betr Entertainment has unveiled an all-scrip takeover bid for PointsBet, offering shareholders 3.81 betr shares per PointsBet share, valuing the offer above a competing cash bid and promising significant cost synergies.

Platinum Capital Limited has released detailed worked examples for its proposed scheme of arrangement, outlining a special dividend payout and the exchange ratio for shares into ETF units. The final dividend value and unit allocation will be confirmed closer to the scheme implementation date.

Platinum Asia Investments has released illustrative calculations for its Special Dividend and Scheme consideration tied to a proposed restructure, offering shareholders clarity ahead of a pivotal vote.

NSX Limited has updated its Scheme Implementation Deed with CNSX Markets Inc., extending the shareholder approval deadline and allowing greater flexibility in acquisition structuring.

Rapid Critical Metals has completed its capital consolidation and placement, reshaping its issued capital structure with shareholder approval.

Imugene Limited has launched a $37.5 million equity raising through a Placement and Share Purchase Plan, offering new shares and options to fund its pivotal azer-cel clinical program. The raise includes attaching and piggyback options, subject to shareholder approval, aiming to bolster the company’s immuno-oncology pipeline.

Imugene Limited has completed a $22.5 million institutional placement and launched a $15 million Share Purchase Plan, both featuring attaching options, to fund its azer-cel clinical program through a pivotal trial in 2026.

Caspin Resources has completed the second tranche of its $2.1 million capital raising, issuing shares and free-attaching options approved by shareholders. The move strengthens funding for its diverse Australian mineral projects.

Close the Loop Limited announces a strategic leadership overhaul with new CEOs appointed for North America and Australia, alongside a streamlined operational focus on three core business units.